US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class II · Moderate risk Terminated

Back Relief II

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-740-00 D-0551-2022
Class II · Moderate risk Terminated

Pain Aid PMF Caplet

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-710-00 D-0550-2022
Class II · Moderate risk Terminated

Normed Fem Tablet

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-701-00 D-0549-2022
Class II · Moderate risk Terminated

APAP 325 mg

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-700-00 D-0548-2022
Class II · Moderate risk Terminated

Migrenol Caplet

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-565-00 D-0547-2022
Class II · Moderate risk Terminated

Phenylephrine HCl 5 mg Tablet

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-333-00 D-0545-2022
Class II · Moderate risk Terminated

Nutralox Peppermint Antacid

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-312-00 D-0543-2022
Class II · Moderate risk Terminated

Spearmint Antacid Tablet

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-311-00 D-0542-2022
Class II · Moderate risk Terminated

Trial Antacid Tablet

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-310-00 D-0541-2022
Class II · Moderate risk Terminated

Cherry Antacid Tablet

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-304-00 D-0540-2022
Class II · Moderate risk Terminated

Peppermint Antacid tablet

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-303-00 D-0539-2022
Class II · Moderate risk Terminated

HPC Tablet

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62969-242-00 D-0538-2022
Class II · Moderate risk Terminated

APAP 500 mg SRC Coated

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-211-00 D-0537-2022
Class II · Moderate risk Terminated

APAP 500 mg tablet

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-210-00 D-0536-2022
Class II · Moderate risk Terminated

Extra-Strength Unaspirin caplet

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-207-00 D-0535-2022
Class II · Moderate risk Terminated

Coated APAP 500 mg caplet

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-206-00 D-0534-2022
Class II · Moderate risk Terminated

Normed APAP 325 mg

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-203-00 D-0533-2022
Class II · Moderate risk Terminated

Coated APAP 325mg

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-202-00 D-0532-2022
Class II · Moderate risk Terminated

APAP 325 mg

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-200-00 D-0531-2022
Class II · Moderate risk Terminated

APAP 500 mg Phenyl HCl 5mg tablet

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-140-00 D-0530-2022
Class II · Moderate risk Terminated

APAP 325 mg/Phenylephrine HCl

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-135-00 D-0529-2022
Class II · Moderate risk Terminated

Dologen 325 Caplet

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-121-00 D-0527-2022